BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26028405)

  • 21. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study.
    Keller MK; Hasslöf P; Stecksén-Blicks C; Twetman S
    Acta Odontol Scand; 2011 Sep; 69(5):263-8. PubMed ID: 21306197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative Abundances of Candida albicans and Candida glabrata in
    Olson ML; Jayaraman A; Kao KC
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
    [No Abstract]   [Full Text] [Related]  

  • 23. Exoproteome Analysis of Antagonistic Interactions between the Probiotic Bacteria
    Savinova OS; Glazunova OA; Moiseenko KV; Begunova AV; Rozhkova IV; Fedorova TV
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics of drug resistance in Candida glabrata biofilms.
    Seneviratne CJ; Wang Y; Jin L; Abiko Y; Samaranayake LP
    Proteomics; 2010 Apr; 10(7):1444-54. PubMed ID: 20127690
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Stivala A; Carota G; Fuochi V; Furneri PM
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33450875
    [No Abstract]   [Full Text] [Related]  

  • 26. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
    Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
    J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofilms.
    Madhwani T; McBain AJ
    Arch Oral Biol; 2011 Nov; 56(11):1264-73. PubMed ID: 21570060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between Lactobacillus rhamnosus GG and oral micro-organisms in an in vitro biofilm model.
    Jiang Q; Stamatova I; Kainulainen V; Korpela R; Meurman JH
    BMC Microbiol; 2016 Jul; 16(1):149. PubMed ID: 27405227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions.
    Jiang Q; Stamatova I; Kari K; Meurman JH
    Benef Microbes; 2015; 6(3):361-8. PubMed ID: 25380800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Randomized Controlled Open Label Crossover Trial to Study Vaginal Colonization of Orally Administered Lactobacillus Reuteri RC-14 and Rhamnosus GR-1 in Pregnant Women at High Risk for Preterm Labor.
    Yefet E; Colodner R; Strauss M; Gam Ze Letova Y; Nachum Z
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates.
    Coman MM; Verdenelli MC; Cecchini C; Silvi S; Orpianesi C; Caspani M; Mondello F; Cresci A
    J Appl Microbiol; 2015 Nov; 119(5):1383-90. PubMed ID: 26335148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lab-scale preparations of Candida albicans and dual Candida albicans-Candida glabrata biofilms on the surface of medical-grade polyvinyl chloride (PVC) perfusion tube using a modified gravity-supported free-flow biofilm incubator (GS-FFBI).
    Shao J; Lu K; Tian G; Cui Y; Yan Y; Wang T; Zhang X; Wang C
    J Microbiol Methods; 2015 Feb; 109():41-8. PubMed ID: 25528294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women.
    Bisanz JE; Seney S; McMillan A; Vongsa R; Koenig D; Wong L; Dvoracek B; Gloor GB; Sumarah M; Ford B; Herman D; Burton JP; Reid G
    PLoS One; 2014; 9(8):e104511. PubMed ID: 25127240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of multiple candidate probiotic bacteria reveals specificity in the ability to modify the effects of key wound pathogens.
    Alhubail M; McBain AJ; O'Neill CA
    Microbiol Spectr; 2024 Jun; 12(6):e0034724. PubMed ID: 38700333
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Hu MX; He F; Guo YX; Mo LZ; Zhu X
    J Agric Food Chem; 2022 Sep; 70(38):11935-11943. PubMed ID: 36111836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of major facilitator superfamily transporter Qdr2p in biofilm formation by Candida glabrata.
    Widiasih Widiyanto T; Chen X; Iwatani S; Chibana H; Kajiwara S
    Mycoses; 2019 Dec; 62(12):1154-1163. PubMed ID: 31519064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Candida krusei and Candida glabrata on Candida albicans gene expression in in vitro biofilms.
    Barros PP; Ribeiro FC; Rossoni RD; Junqueira JC; Jorge AO
    Arch Oral Biol; 2016 Apr; 64():92-101. PubMed ID: 26803674
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Parolin C; Croatti V; Laghi L; Giordani B; Tondi MR; De Gregorio PR; Foschi C; Vitali B
    Front Microbiol; 2021; 12():750368. PubMed ID: 34777300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geraniol eradicates Candida glabrata biofilm by targeting multiple cellular pathways.
    Gupta P; Gupta H; Poluri KM
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5589-5605. PubMed ID: 34196746
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Dube Y; Khan A; Marimani M; Ahmad A
    Can J Microbiol; 2020 Dec; 66(12):733-747. PubMed ID: 32777192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.